People diagnosed with chronic myeloid leukemia (CML) receive state-of-the-art care from a team of specialists at Seattle Cancer Care Alliance who focus almost exclusively on treating this disease. SCCA was formed, in part, to bring promising new treatments to patients faster. For the CML patient, this means more treatment options than might be found elsewhere, including participation in one or more of the 50 ongoing leukemia clinical research studies conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
If your condition requires a bone marrow transplant, you should know that the Fred Hutchinson Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutchinson Center pioneered the use of bone marrow transplants as a treatment for blood diseases over 40 years ago. Since then thousands of patients with leukemia have come from around the world to receive bone marrow transplants at SCCA. Bone marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.
Myelogenous or myeloid leukemias occur in bone marrow cells that normally become red blood cells, some white blood cells, and platelets. Read more about CML in this section.
Learn about several treatment options that are available for CML patients.
Our doctors are members of Fred Hutchinson Cancer Research Center and faculty from UW Medicine and Seattle Children's. They work as a team to care for people with Chronic Myeloid Leukemia.
Receiving a diagnosis for Chronic Myeloid Leukemia leads to many questions. SCCA physicians and staff provide compassionate care and support during your course of treatment so you will always know what to expect.
As a world-class treatment center, SCCA provides patients with the best and most current therapies available. Clinical studies bring promising new treatments to patients faster. And participating in a study gives patients at least the best, current treatment, as well as the satisfaction that they are helping others with Chronic Myeloid Leukemia.
Because treatment for Chronic Myeloid Leukemia isn't easy, special support for patients is essential. SCCA has several programs, classes, and services to assist patients and their families.
The more you know about your disease, the more empowered you'll feel. This list of reputable sources about Chronic Myeloid Leukemia - Adult makes gathering information easy.
